Cytosine arabinoside (Ara-C) plus alpha-interferon (-IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimens / Palmieri, G., A., M., A., R., M., C., P., T., A. R., B.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 88:(1994), pp. 421-423.

Cytosine arabinoside (Ara-C) plus alpha-interferon (-IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimens.

PALMIERI, GIOVANNELLA;
1994

1994
Cytosine arabinoside (Ara-C) plus alpha-interferon (-IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimens / Palmieri, G., A., M., A., R., M., C., P., T., A. R., B.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 88:(1994), pp. 421-423.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/337647
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact